NewAmsterdam Pharma Co N.V (NAMS) Leases: 2022-2025
Historic Leases for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to $246,000.
- NewAmsterdam Pharma Co N.V's Leases fell 50.10% to $246,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $246,000, marking a year-over-year decrease of 50.10%. This contributed to the annual value of $431,000 for FY2024, which is 683.64% up from last year.
- Per NewAmsterdam Pharma Co N.V's latest filing, its Leases stood at $246,000 for Q3 2025, which was down 20.13% from $308,000 recorded in Q2 2025.
- In the past 5 years, NewAmsterdam Pharma Co N.V's Leases registered a high of $554,000 during Q2 2024, and its lowest value of $38,000 during Q1 2024.
- In the last 3 years, NewAmsterdam Pharma Co N.V's Leases had a median value of $338,500 in 2025 and averaged $311,750.
- Its Leases has fluctuated over the past 5 years, first crashed by 54.17% in 2023, then spiked by 871.05% in 2025.
- NewAmsterdam Pharma Co N.V's Leases (Quarterly) stood at $120,000 in 2022, then plummeted by 54.17% to $55,000 in 2023, then spiked by 683.64% to $431,000 in 2024, then slumped by 50.10% to $246,000 in 2025.
- Its Leases stands at $246,000 for Q3 2025, versus $308,000 for Q2 2025 and $369,000 for Q1 2025.